1189986-59-1
1189986-59-1
Chemical Structure
Haloperidol-d4
- CAS. Nr.: 1189986-59-1
- Formula:C21H19D4ClFNO2
- Molecular Weight:379.89
IUPAC Name: 4-(4-(4-chlorophenyl-2,3,5,6-d4)-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butan-1-one
InChIKey: LNEPOXFFQSENCJ-KDWZCNHSSA-N
SMILES: ClC1=C([2H])C([2H])=C(C2(O)CCN(CCCC(C3=CC=C(F)C=C3)=O)CC2)C([2H])=C1[2H]
Biological Activity: Haloperidol-d4 is deuterium labeled haloperidol, and the latter is a potent dopamine D2 receptor antagonist.
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Haloperidol-d4 | Haloperidol-d4 is deuterium labeled haloperidol, and the latter is a potent dopamine D2 receptor antagonist. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Haloperidol (Standard) | 99.84% | Haloperidol (Standard) is the analytical standard of Haloperidol. This product is intended for research and analytical applications. Haloperidol is a potent dopamine D2 receptor antagonist, widely used as an antipsychotic. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Haloperidol-d4 N-Oxide | Haloperidol-d4 N-Oxide is the deuterium labeled Haloperidol. Haloperidol is a potent dopamine D2 receptor antagonist, widely used as an antipsychotic. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Haloperidol-13C6 | Haloperidol-13C6 is the 13C6 labeled Haloperidol. Haloperidol is a potent dopamine D2 receptor antagonist, widely used as an antipsychotic. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Haloperidol-d4-1 | 98.0% | Haloperidol-d4-1 is deuterium labeled haloperidol, and the latter is a potent dopamine D2 receptor antagonist. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Haloperidol | 99.69% | Haloperidol is a potent dopamine D2 receptor antagonist, widely used as an antipsychotic agent. Haloperidol can be used in the study of schizophrenia, tics in Tourette syndrome, mania in bipolar disorder, delirium, agitation, acute psychosis, and hallucinations from alcohol withdrawal. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
